Naruyasu Kakita
Kaizuka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Hepatologist-Driven Screening for Obstructive Sleep Apnea in Patients With MASLD Using a Modified STOP-Bang Questionnaire: The SOMA Model.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 10, 2026
Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All-Cause Mortality After SVR in Advanced Chronic Hepatitis C.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: March 27, 2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Journal for immunotherapy of cancer
Published: March 16, 2026
Monocyte-derived IL-1β predicts and promotes HBsAg decline in chronic hepatitis B patients under nucleoside analogue therapy.
Journal: Hepatology communications
Published: October 31, 2025
Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma.
Journal: Journal of gastroenterology
Published: July 29, 2025
Histopathological changes in two patients with hypertriglyceridemia and metabolic dysfunction-associated steatotic liver disease treated with pemafibrate: a serial liver biopsy study.
Journal: Clinical journal of gastroenterology
Published: June 08, 2025
Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma.
Journal: Journal of gastroenterology and hepatology
Published: March 24, 2025
Multidisciplinary treatment for metastasis in left perinephric space after the resection of left renal metastasis in a patient with hepatocellular carcinoma:a case report
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
Published: December 11, 2024
Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis.
Journal: Alimentary pharmacology & therapeutics
Published: February 02, 2024
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD.
Journal: Hepatology communications
Published: December 30, 2023
Possible pathogenetic role of ammonia in liver cirrhosis without hyperammonemia of venous blood: The so-called latency period of abnormal ammonia metabolism.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 25, 2023
Last Updated: 09/26/2026